Apyx Medical Corporation - Common Stock (NQ:APYX)

2.525 -0.045 (-1.75%)

Delayed Quote Updated: 12:37 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apyx Medical Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Are Apyx Medical Shares Trading Higher Today? ↗

May 26, 2022

Via Benzinga

Mid-Day Market Update: Crude Oil Jumps Over 3%; NRx Pharmaceuticals Shares Tumble ↗

May 26, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 1.5% on Thursday.

Via Benzinga

61 Stocks Moving In Thursday's Mid-Day Session ↗

May 26, 2022

Via Benzinga

Apyx Medical: Q1 Earnings Insights ↗

May 12, 2022

Apyx Medical (NASDAQ:APYX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Apyx Medical Earnings Preview ↗

March 16, 2022

Apyx Medical (NASDAQ:APYX) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; US Economy Contracts 1.5% In Q1 ↗

May 26, 2022

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 200 points on Thursday.

Via Benzinga

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures

May 26, 2022

From Apyx Medical Corporation

Via Business Wire

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June

May 25, 2022

From Apyx Medical Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022 ↗

May 20, 2022

Upgrades

Via Benzinga

NASDAQ:APYX Investor Notice: Investigation over Possible Securities Laws Violations by Apyx Medical Corporation ↗

May 13, 2022

San Diego, CA -- (SBWIRE) -- 05/13/2022 -- Apyx Medical Corporation is under investigation concerning potential securities laws violations in connection with certain financial statements.

Via SBWire

Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

May 12, 2022

From Apyx Medical Corporation

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 25, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Continues Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 23, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 22, 2022

From Law Offices of Howard G. Smith

Via Business Wire

APYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corp. on Behalf of Apyx Stockholders and Encourages Investors to Contact the Firm

April 21, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 21, 2022

From Law Offices of Howard G. Smith

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 20, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 14, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022

April 04, 2022

From Apyx Medical Corporation

Via Business Wire

Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin

April 04, 2022

From Apyx Medical Corporation

Via Business Wire

38 Stocks Moving In Wednesday's Mid-Day Session ↗

March 23, 2022

Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted...

Via Benzinga

Apyx Medical's Return on Invested Capital Insights ↗

March 18, 2022

According to data from Benzinga Pro, during Q4, Apyx Medical's (NASDAQ:APYX) reported sales totaled $16.82 million. Despite a 52.53% increase in earnings, the company posted a...

Via Benzinga

Apyx Medical: Q4 Earnings Insights ↗

March 17, 2022

Apyx Medical (NASDAQ:APYX) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook

March 17, 2022

From Apyx Medical Corporation

Via Business Wire

Earnings Scheduled For March 17, 2022 ↗

March 17, 2022

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...

Via Benzinga

96 Biggest Movers From Yesterday ↗

March 15, 2022

Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share. Incannex...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 14, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 48.0% to $20.95 during Monday's regular session. The company's market cap stands at $1.0 billion....

Via Benzinga

50 Stocks Moving In Monday's Mid-Day Session ↗

March 14, 2022

Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share. AgriFORCE Growing Systems,...

Via Benzinga

Apyx Medical Corporation Notified of Pending FDA Medical Device Safety Communication Related to its Advanced Energy Products

March 14, 2022

From Apyx Medical Corporation

Via Business Wire

Apyx Medical Submits Additional FDA 510(k) For Expanded Use Of Renuvion In Dermatological Procedures ↗

February 17, 2022

Apyx Medical Corporation (NASDAQ: APYX) announced the publication of an article in a journal featuring the results of its U.S. IDE study evaluating the Renuvion Dermal...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.